Skip to main content
. 2021 Sep 19;38(10):5361–5380. doi: 10.1007/s12325-021-01904-6

Table 2.

Additional secondary endpoints

Endpoint
1 Change from baseline to the average of weeks 12–28 in FACT-An
2 Change from baseline to the average of weeks 12–28 in EQ-5D-5L
3 Change from baseline to the average of weeks 12–28 in PGIC
4 Occurrence and duration of hospitalizations
5 Serum hepcidin
6 Serum ferritin
7 Transferrin saturation

EQ-5D-5L European Quality of Life 5-Dimension 5-Level, FACT-An Functional Assessment of Cancer Therapy-Anemia, PGIC Patients’ Global Impression of Change